Patent Use Codes In The Wake Of Caraco V. Novo Nordisk
The U.S. Supreme Court, in a unanimous decision in Caraco Pharmaceutical Laboratories Ltd. v. Novo Nordisk A/S, No. 10-844 (U.S. April 17, 2012), held that generic drug companies may counterclaim to...To view the full article, register now.
Already a subscriber? Click here to view full article